INACTIVE INGREDIENT SECTION
Acrylates copolymer, Ethyl acetate
Acrylates copolymer, Ethyl acetate
If sxralowed, get medical help or contact a Poison Conirol Cenler ngiht away.
on broken or irritated scalp
When using this product, avoid contact with eyes. lf contact occurs, rinse thoroughly with waterDiscontinue use if any irritation or adverse reaction occurs.
Discontinue use if any irritation or adverse reaction occurs
For external use only.
Apply twice daly(moring and night as a man and once as a woman.Afer apicaion, proeed with an acive masage for 3-5 minutes unthe product is fuy absorbed
wart remover
Salicylic acid 2%
| Class | Version | Type | Effective |
|---|---|---|---|
| MINOXIDIL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 84515-250-01 | 2024-12-23 | C162847 | 48780-1 | 29f3fba1-5b6a-85bd-e063-dadaa90a46bf | 2406f7c2-a69a-1029-e063-6394a90a1ce8 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84515-250-01 | Hair Strengthening Oil | 100 mL in 1 BOX | LIQUID | 100 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84515-250 | 84515-250-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHLORPHENESIN | I670DAL4SZ | IACT |
| SESAME OIL | QX10HYY4QV | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PALMITOYL TRIPEPTIDE-1 | RV743D216M | IACT |
| MINOXIDIL | 5965120SH1 | ACTIB |
| PALMITOYL TETRAPEPTIDE-7 | Q41S464P1R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2406f7c2-a69b-1029-e063-6394a90a1ce8 | 2406f7c2-a69a-1029-e063-6394a90a1ce8 | 2024-10-09 | 2406f7c2-a69b-1029-e063-6394a90a1ce8 2406f7c2-a69a-1029-e063-6394a90a1ce8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.